Zhejiang Huaye Plastics Machinery
301616
Alnera Aluminium
301613
Glory View Technology
301396
4
Guangzhou Sie Consulting
300687
5
Tibet Duo Rui Pharmaceutical
301075
(Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 580.73%3.27M | -84.25%361.54K | -77.41%704.9K | -15.37%8.4M | 203.76%6.96M | -70.06%480.77K | -6.05%2.3M | -12.92%3.12M | -38.38%9.92M | -42.68%2.29M |
Operating revenue | 580.73%3.27M | -84.25%361.54K | -77.41%704.9K | -15.37%8.4M | 203.76%6.96M | -70.06%480.77K | -6.05%2.3M | -12.92%3.12M | -38.38%9.92M | -42.68%2.29M |
Cost of revenue | 416.00%744.23K | -73.78%432.43K | -80.57%432.78K | -29.95%5M | 141.95%4.57M | -73.09%144.23K | -23.55%1.65M | -13.06%2.23M | -39.85%7.14M | -47.16%1.89M |
Gross profit | 651.33%2.53M | -110.96%-70.88K | -69.52%272.12K | 22.14%3.39M | 495.56%2.38M | -68.54%336.54K | 125.39%646.96K | -12.59%892.75K | -34.23%2.78M | -4.44%400.31K |
Operating expense | 104,792.65%2M | -32.50%1.3M | 28.39%3.53M | -60.23%9.84M | -28.44%9.83M | -99.91%1.91K | -59.96%1.92M | -32.84%2.75M | -51.43%24.74M | 87.66%13.74M |
Selling and administrative expenses | 104,792.65%2M | -32.50%1.3M | 28.39%3.53M | -60.13%9.84M | -28.44%9.83M | -99.91%1.91K | -59.84%1.92M | -32.52%2.75M | -50.85%24.67M | 92.46%13.74M |
-Selling and marketing expense | ---- | -56.05%134.06K | -39.70%146.14K | -18.84%1.57M | ---- | ---- | -12.13%305.04K | -67.98%242.35K | -44.55%1.93M | -48.67%553.52K |
-General and administrative expense | 104,792.65%2M | -28.05%1.16M | 34.97%3.38M | -63.63%8.27M | -37.30%8.27M | -99.90%1.91K | -63.57%1.62M | -24.42%2.51M | -51.32%22.74M | 117.58%13.18M |
Research and development costs | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -91.15%65.16K | --0 |
Operating profit | 58.47%530.29K | -7.34%-1.37M | -75.51%-3.26M | 70.66%-6.44M | 44.16%-7.45M | 132.16%334.63K | 71.75%-1.27M | 39.58%-1.85M | 52.99%-21.96M | -93.25%-13.34M |
Net non-operating interest income expense | 99.13%-3.16K | -14.06%-965.7K | 54.12%-2.42M | 14.60%-365.15K | 72.90%-846.68K | 48.48%-5.27M | 69.61%-1.3M | |||
Non-operating interest expense | ---- | -99.13%3.16K | 14.06%965.7K | -54.12%2.42M | ---- | ---- | -14.60%365.15K | -72.90%846.68K | -48.48%5.27M | -69.61%1.3M |
Other net income (expense) | -4 | -99.86%4.91K | -99.99%154 | 84.58%-6.77M | 181.37%3.4M | -49.71%1.85M | -521.59%-43.92M | -8.10%7.65M | ||
Gain on sale of security | ---4 | -99.86%4.91K | -99.99%154 | -431.83%-6.48M | ---- | ---- | 181.37%3.4M | -41.84%2.14M | -89.47%1.95M | 119.81%7.65M |
Special income (charges) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -1,939.17%-45.88M | --0 |
-Gain on sale of business | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---45.88M | --0 |
Other non- operating income (expenses) | ---- | ---- | ---- | ---289.98K | ---- | ---- | ---- | ---289.98K | ---- | ---- |
Income before tax | 58.47%530.29K | -177.53%-1.37M | -398.46%-4.22M | 78.02%-15.64M | -138.26%-16.64M | 100.68%334.63K | 119.32%1.76M | 66.22%-846.77K | -52.93%-71.15M | -144.66%-6.98M |
Income tax | 577.12%373.88K | 0 | 0 | 0 | -165.58K | 55.22K | 0 | 0 | 0 | 0 |
Net income | -44.02%156.41K | -177.53%-1.37M | -398.46%-4.22M | 78.02%-15.64M | -135.89%-16.47M | 100.57%279.42K | 115.99%1.76M | 80.15%-846.77K | -37.43%-71.15M | 2.23%-6.98M |
Net income continuous Operations | -44.02%156.41K | -177.53%-1.37M | -398.46%-4.22M | 78.02%-15.64M | -135.89%-16.47M | 100.57%279.42K | 119.32%1.76M | 66.22%-846.77K | -52.93%-71.15M | -144.66%-6.98M |
Minority interest income | 567.62K | 0 | ||||||||
Net income attributable to the parent company | -247.17%-411.21K | -177.53%-1.37M | -398.46%-4.22M | 78.02%-15.64M | -135.89%-16.47M | 100.57%279.42K | 115.99%1.76M | 80.15%-846.77K | -37.43%-71.15M | 2.23%-6.98M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -247.17%-411.21K | -177.53%-1.37M | -398.46%-4.22M | 78.02%-15.64M | -135.89%-16.47M | 100.57%279.42K | 115.99%1.76M | 80.15%-846.77K | -37.43%-71.15M | 2.23%-6.98M |
Basic earnings per share | -96.77%0.01 | -100.62%-0.24 | 1.04%-38.2 | 87.24%-648.8 | 94.57%-9.0096 | 100.01%0.31 | 101.99%38.64 | 92.05%-38.6 | 52.78%-5.08K | 86.28%-165.78 |
Diluted earnings per share | -80.00%0.01 | -157.14%-0.24 | 1.04%-38.2 | 87.24%-648.8 | 94.57%-9.0096 | 100.00%0.05 | 100.02%0.42 | 92.05%-38.6 | 52.78%-5.08K | 86.28%-165.78 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |